Driving a stake into resurgent TB.
Enserink
M
M
D000328:Adult; D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000191:economics; D002648:Child; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D016680:Genome, Bacterial; D014943:Global Health; D006801:Humans; D009166:Mycobacterium leprae / Q000235:genetics; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000276:immunology; D014376:Tuberculosis / Q000191:economics / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D018088:Tuberculosis, Multidrug-Resistant / Q000276:immunology / Q000517:prevention & control; D019444:Vaccines, DNA / Q000235:genetics; D014614:Vaccines, Synthetic / Q000235:genetics
D001500:BCG Vaccine; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic